EPIDEMIOLOGY OF CYSTICERCOSIS IN MADAGASC AR

By examining the sera from 1,408 healthy individuals in all six provin ces of Madagascar with ELISA methods, we were able to demonstrate a ve ry high prevalence for cysticercosis: 18 %. The serologic markers for cysticercosis among 1,132 patients with neurologic symptoms was even h igher: 36 %. Furthermore, of 241 patients with neurocysticercosis, 82 % of the serums recognized, in Western Blot test, the 14-20 Kd << evol utivity proteins >>. Cysticercosis is thus highly implicated in the ne urologic syndroms found in Madagascar. Only adequate prophylaxis will permit a reduction in the incidence of this disease.